Shanghai Sanyou Medical Co., Ltd.

688085.SS · SHH

Market open13.18-0.360000 (-2.66%)

Key statistics

Previous close13.54

Open12.88

Day high13.21

Day low13.18

52-week high23.75

52-week low11.12

Market cap4.83B

Volume10.23K

Average volume4.85M

P/E ratio76.49

Forward P/E—

EPS0.17

Dividend yield+0.15%

Market context

Why it moved

Shares of 688085.SS declined today amid broad market selling pressure and a lack of positive catalysts, as thin trading volume and weak investor sentiment weighed on the stock.

Instagram

What is happening

Recent company-specific developments and publisher coverage.

Mt Newswire · March 5, 2026Shanghai Sanyou Medical's Implanet Secures FDA Clearance for 3D-Printed Spinal System

Mt Newswire · February 12, 2026Sanyou Medical to Acquire Stake in Zhuiyuan Medical for 20 Million Yuan

Peers

Stryker CorporationSYK · $319.87-3.42%

Medtronic plcMDT · $83.20-0.43%

Globus Medical, Inc.GMED · $77.00-4.83%

Alphatec Holdings, Inc.ATEC · $8.54-7.93%

Orthofix Medical Inc.OFIX · $11.58-2.61%

Enovis CorporationENOV · $27.07-3.56%

Beijing Chunlizhengda Medical Instruments Co., Ltd.688236.SS · 14.53-8.50%

Company profile

Shanghai Sanyou Medical Co., Ltd. (688085.SS) is a Shanghai-based medical device company founded in 2005 that specializes in the research, development, manufacturing, and sales of orthopedic implant consumables in China. The company markets its products under the Tytus and Sanyou brand names, with a primary focus on spinal and trauma implants, including anterior cervical plates, thoracolumbar systems, posterior cervical solutions, and minimally invasive products, as well as trauma implants covering the shoulder, elbow, hip, pelvis, knee, and wrist regions. Listed on the Shanghai Stock Exchange's STAR Market in April 2020, Sanyou Medical is recognized as one of the few domestic enterprises with original innovation capabilities rooted in clinical needs, holding over 395 patents and 27 Class III medical device registration certificates as of end-2021. With a workforce of approximately 466 employees and a market capitalization of around CNY 4.65 billion, the company continues to strengthen its position as a leading domestic player in China's orthopedic implant market.

Symbol: 688085.SS
Exchange: SHH
Sector: Healthcare
Industry: Medical - Devices
CEO: Nong Xu
Employees: 539
Country: CN
IPO date: 2020-04-09
Website: sanyoumed.com

Analyst consensus

hold

0 ratings

Low0.00Average0.00High0.00